lunes, 23 de febrero de 2026

Pharma lobbyists focus on a surprising new target: the FDA The FDA has long been shielded from political influence, but that’s changing under Trump

https://www.statnews.com/2026/02/23/fda-lobbying-efforts-grow-under-trump-administration/ By Daniel Payne and Lizzy LawrenceFeb. 23, 2026 Daniel Payne and Lizzy Lawrence interviewed lobbyists and government officials and reviewed corporate disclosures for this story.

No hay comentarios: